SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.70-3.6%Jan 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (14004)7/6/2000 7:49:12 AM
From: Oak Tree  Read Replies (1) of 17367
 
In the case of LBP however, a little is good a lot is bad. The same is true, but little known, about TNF. Low doses of TNF are a very powerful growth factor, yes growth factor. Its so powerful, that it must have its own feedback loop, and becomes a very powerful killer if the dose increases to even low detectable levels.

By this argument, low levels of BPI might be bad and high levels good -- hence the need for 15x or higher. Even however if this is true, it supports my previous statements. This drug is hard to use safely and effectively, the moon and stars have to be in the correct orbit. This is not a robust reliable antimicrobial therapy.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext